author-photo

S. H. Park

Sungkyunkwan University

19

Papers

908

Citations

Citation Trend

Filter By

Papers (9) Sort By

Journal Conference Others

Phase III, randomised trial of avelumab versus physician’s choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300

2018 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (208)
Efficacy and safety findings from DREAM: A phase III study of DHP107 (oral paclitaxel) versus i.v. paclitaxel in patients with advanced gastric cancer after failure of first-line chemotherapy

2018 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (24)
A study on MFL based wire rope damage detection

2017 Proceedings of SPIE
Show All
- Source
- Cite
- Save
Citations (3)
Feasibility of Nipple-Sparing Mastectomy with Immediate Breast Reconstruction in Breast Cancer Patients with Tumor-Nipple Distance Less Than 2.0 cm

2016 World Journal of Surgery
Show All
- Source
- Cite
- Save
Citations (17)
P-072Overall survival (OS) of patients with advanced gastric cancer (AGC) according to the availability of 5-FU, platinum, taxanes and irinotecan as first, second and third-line chemotherapy

2015 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Oxaliplatin, 5-FU, and leucovorin (FOLFOX) in advanced biliary tract cancer.

2011 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)
Imatinib efficacy by tumor genotype in Asian patients with metastatic or recurrent gastrointestinal stromal tumors (GISTs): A retrospective study of Korean GIST Study Group (KGSG).

2011 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Treatment outcomes of chemotheraphy for advanced gastric cancer with disseminated intravascular coagulation.

2011 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
A phase II study of sorafenib in patients with metastatic or unresectable gastrointestinal stromal tumors with failure of both imatinib and sunitinib: A KGSG study.

2011 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (5)